SCAPER, a novel cyclin A–interacting protein that regulates cell cycle progression by Tsang, William Y. et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $15.00
The Journal of Cell Biology, Vol. 178, No. 4, August 13, 2007 621–633
http://www.jcb.org/cgi/doi/10.1083/jcb.200701166
JCB 621
Introduction
Cyclin-dependent kinases (Cdks) play a key role in mammalian 
cell cycle regulation by ensuring that cell cycle events proceed 
in a stepwise fashion and produce two identical daughter cells. 
Several cyclin/Cdk complexes have been implicated in cell 
cycle control (Sherr and Roberts, 2004). In mammalian cells, 
entry into mitosis is governed by cyclin A/Cdk1 and cyclin B/Cdk1. 
Another Cdk activity, cyclin A/Cdk2, is required for both DNA 
synthesis and mitosis (Pagano et al., 1992). Cyclin A/Cdk2 
activity is fi  rst evident in late G1, and it persists through S and G2 
phase until prometaphase (Furuno et al., 1999; den Elzen and 
Pines, 2001; Geley et al., 2001). To date, two known isoforms of 
mammalian cyclin A (cyclin A1 and A2) are present. Although 
cyclin A1 is restricted to male germ cells, cyclin A2 (hereafter 
referred to as cyclin A) is widely expressed in both germ cells 
and somatic tissues (Howe et al., 1995; Sweeney et al., 1996). 
Cyclin A–defi  cient mice die during early embryogenesis (Murphy, 
1999), demonstrating that cyclin A is an essential gene.
The requirements for cyclin A in both replication and 
mitosis have not been fully elucidated. A number of experimental 
approaches have suggested potential mechanisms whereby 
cyclin A/Cdk2 complexes regulate the G1/S transition. Over-
expression of cyclin A accelerated entry of mammalian cells 
into S phase, indicating that this cyclin could be a limiting fac-
tor needed to trigger replication (Resnitzky et al., 1995). Con-
versely, microinjection of anti-cyclin A antibodies or production 
of antisense RNA in G1 phase cells prevented entry into S phase 
(Girard et al., 1991). It has been proposed that cyclin A/Cdk2 
is required for the initiation of replication, activation of pre-
existing replication complexes, and/or prevention of rereplication 
(Saha et al., 1998; Petersen et al., 1999; Coverley et al., 2002). 
In support of these mechanisms, cyclin A has been found to 
associate with DNA replication foci in human cells, and it has 
been shown to bind to and phosphorylate proteins in the origin 
recognition complex in Xenopus extracts (Cardoso et al., 1993; 
Romanowski et al., 2000). Cyclin A has also been shown to 
associate with and phosphorylate Cdc6, provoking its nuclear 
export and degradation and thereby preventing rereplication 
(Saha et al., 1998; Petersen et al., 1999).
The mechanisms by which cyclin A promotes entry into, 
and progression through, mitosis are also unclear. This is likely 
due, at least in part, to the functional overlap with another mitotic 
kinase, cyclin B/Cdk1. Nevertheless, it is clear that cyclin A plays 
an essential role in mitotic entry because microinjection of anti-
cyclin A antibodies into G2 phase cells can prevent progression 
into M phase (Pagano et al., 1992). Microinjection of recombi-
nant cyclin A/Cdk2 into human G2 (but not S phase) cells accel-
erated entry into mitosis, suggesting that this kinase may be 
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a rate-limiting factor for the G2/M transition (Furuno et al., 1999). 
Interestingly, cyclin A/Cdk2 was also required to progress through 
mitosis until the middle of prophase because the inhibition of 
this kinase with a Cdk inhibitor caused early or mid-prophase 
cells to return to interphase (Furuno et al., 1999). Cyclin A is 
destroyed by the anaphase-promoting complex in pro-metaphase, 
and mutants lacking a destruction box arrest in anaphase (Geley 
et al., 2001). In light of these experiments and others, it will be 
critical to determine the key substrates of this kinase, how they 
enable progression through replication and mitosis, and whether 
these targets are specifi  c to cyclin A/Cdk complexes.
In addition to its role in activating Cdks, the cyclin com-
ponent is critical for directing kinase activity to particular 
compartments. Cyclins are directed to their substrates through 
signals that regulate both subcellular localization and targeting 
to a specifi  c protein binding site (the so-called RXL or cyclin-
binding motif) (Zhu et al., 1995; Adams et al., 1996; Chen et al., 
1996). Cyclin A had been shown previously to be predominantly 
nuclear by immunofl  uorescence (Pines and Hunter, 1991). Yet it 
is clear that cyclin A/Cdk2 phosphorylates both nuclear and 
 cytoplasmic targets, including those involved in centrosome dupli-
cation (Meraldi et al., 1999). Interestingly, recent data suggest 
that the cyclin A/Cdk complex is not statically maintained in 
the nucleus. Rather, it shuttles between nucleus and cytoplasm, 
consistent with its ability to modify targets in both compart-
ments (Jackman et al., 2002). These and other studies also sug-
gested that Cdk2 was required in vitro and in vivo for nuclear 
import of cyclin A (Maridor et al., 1993). However, the require-
ments for cyclin A nuclear export have not been defi  ned.
In an effort to understand in greater detail how cyclin A is 
regulated, we have performed a biochemical screen for proteins 
that interact with cyclin A in human cells. Our efforts have led 
to the identifi  cation of SCAPER, a novel protein that specifi  -
cally interacts with cyclin A/Cdk2 in vivo through a cyclin-
binding motif. Although a small portion is associated with the 
nucleus, SCAPER localizes primarily to the endoplasmic retic-
ulum (ER), and its expression is relatively constant throughout 
the cell cycle. It associates with cyclin A at multiple stages 
of the cell cycle. Ectopic expression of SCAPER sequesters 
cyclin A from the nucleus and delays cell cycle progression 
in M phase. Furthermore, ablation of SCAPER by RNAi de-
creases the pool of cyclin A in the cytoplasm (manifested as a 
membrane-bound complex), resulting in delayed progression 
into S phase from quiescence (G0) in response to mitogens. Our 
data suggest that the isolation of SCAPER may allow us to dis-
sect the S and M phase functions of the cyclin A/Cdk2 kinase. 
Further, SCAPER binding to cyclin A may represent a mecha-
nism for retaining cyclin A transiently in the cytoplasm and 
directing the kinase to specifi  c substrates that must be phos-
phorylated in that compartment before S phase entry.
Results
Puriﬁ  cation of SCAPER, a cyclin A/Cdk2-
interacting protein
To search for cyclin A/Cdk2-interacting proteins, we took 
  advantage of the observation that cyclins often exhibit stable 
binding to substrates and regulators through dedicated docking 
sites and that the resulting associated proteins can be sub-
sequently phosphorylated in vitro. We biochemically isolated 
proteins that associate with cyclin A in vivo using anti-cyclin A 
immunoaffi  nity purifi  cation. Purifi  ed proteins were subjected to 
in vitro kinase assays and separated by SDS-PAGE, revealing a 
series of phosphorylated species (Fig. 1 A). Given that the Kip/Cip 
family of kinase inhibitors, p21 and p27, and the pRB family pro-
teins, p107 and p130, have been shown to associate with cyclin A 
in vivo, we used a combination of immunodepletion, Western 
blotting, and kinase assay to verify that they were indeed pre-
sent in this collection of polypeptides (Fig. 1 A and unpublished 
data). These results substantiate our approach and suggest that 
physiological cyclin A/Cdk2-interacting proteins can be identi-
fi  ed using this strategy.
In addition to the expected complement of proteins de-
scribed above, we detected a major phosphorylated polypeptide 
of 158/160 kD (p158/p160) that did not correspond to known 
cyclin A–interacting proteins. To further validate the interaction 
between cyclin A and p158/p160, we fractionated whole cell 
extracts using Q- and SP-Sepharose ion exchange columns 
and then performed immunopurifi  cation with anti-cyclin A anti-
body and kinase assays. p107 and p130 appeared in multiple 
fractions (Fig. 1 B), attesting to their heterogeneous representa-
tion in multiple, distinct complexes (Woo et al., 1997). In con-
trast, p158/p160 was detected in a single fraction on either ion 
exchange column, suggesting the existence of stable, specifi  c 
cyclin A/Cdk2 complexes. To further test the notion that p158/
p160 could be isolated by an independent method that also re-
lied on affi  nity for cyclin A/Cdk2, we chromatographed human 
cell extracts over a matrix containing recombinant GST-cyclin A/
Cdk2 and performed kinase assays. GST-cyclin A/Cdk2, but 
not unfused GST protein, interacted with a polypeptide indis-
tinguishable in mobility from p158/p160 (Fig. 1 C). GST-cyclin E/
Cdk2 also bound p158/p160, albeit to a lesser extent, in this 
in vitro experiment.
Puriﬁ  cation and identiﬁ  cation of SCAPER
To identify p158/p160, we performed a large-scale purifi  cation 
of the protein from human cell extracts using resin containing 
recombinant GST-cyclin A/Cdk2 protein. The 158/160-kD band 
was subjected to mass spectrometric sequencing. This analysis 
revealed that a large number of peptides belonged to two unchar-
acterized proteins with similar molecular masses. One of these 
polypeptides has a theoretical molecular weight of 158 kD and 
encoded a putative zinc fi  nger motif (sequenced previously as 
a cDNA designated ZNF291, GenBank/EMBL/DDBJ accession 
no. AF242528; Fig. 1 D). We termed this polypeptide SCAPER 
(S phase cyclin A–associated protein residing in the endoplasmic 
reticulum) in light of our fi  ndings described below. SCAPER 
shows no considerable homology with known human proteins. 
A motif search identifi  ed a putative C2H2-type zinc fi  nger motif, 
a putative transmembrane domain, an ER retrieval signal at the 
C terminus, four coiled-coil domains, six potential RXL motifs 
that might confer binding to cyclins, and six consensus Cdk 
phosphorylation sites (Fig. 1 D). We note the existence of mouse, 
rat, bovine, and chimpanzee SCAPER orthologues.SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 623
We amplifi  ed the coding region, inserted the resulting pro-
duct into an expression vector with a Flag tag, and expressed the 
protein in human 293T cells. Flag-SCAPER was purifi  ed and 
could be phosphorylated in vitro with recombinant cyclin A/Cdk2. 
The resulting phosphoprotein co-migrated with endogenous 
SCAPER (Fig. 2 A), suggesting that we had amplifi  ed the full-
length protein.
We probed Northern blots derived from human tissue and 
found that SCAPER is ubiquitously expressed in each of the 
human tissues we examined, with highest transcript levels in 
Figure 1. Identiﬁ  cation of SCAPER using immunoafﬁ  nity puriﬁ  cation. (A) Proteins interacting with cyclin A were identiﬁ  ed via immunopuriﬁ  cation with 
  cyclin A antibody and kinase assay. Control IgG was used as a control. p21, p27, p107, and p130 were identiﬁ  ed by immunoprecipitation and Western 
blotting as well as immunodepletion. The asterisk indicates an unidentiﬁ  ed polypeptide. (B) p158/p160 complexes with cyclin A were fractionated by 
Q and SP Sepharose ion exchange chromatography and eluted with the indicated concentrations of salt. Complexes were detected as in A. (C) Proteins 
puriﬁ  ed with matrices containing the various GST-tagged complexes were identiﬁ  ed by kinase assays and compared with eluates from anti-cyclin A immuno-
puriﬁ  cation as in A. (D) The complete amino acid sequence of SCAPER. Possible RXL motifs and Cdk phosphorylation sites are highlighted in red and pink, 
respectively. Putative coiled-coil domains are highlighted in cyan; zinc ﬁ  nger motif in blue; ER retrieval signal in orange; and transmembrane motif in purple. 
Peptides sequenced by mass spectrometry are underlined.JCB • VOLUME 178 • NUMBER 4 • 2007  624
testis (Fig. 2 B). Next, we determined whether SCAPER was 
expressed in a cell cycle–dependent manner. We synchronized 
human T98G cells by means of serum deprivation and restimu-
lation and prepared total RNA from cells at each stage. Semi-
quantitative RT-PCR revealed that SCAPER was expressed at 
each stage of the cell cycle, although the gene was expressed at 
somewhat higher levels in late G1 and S phase (Fig. 2 C). It is 
worth noting that SCAPER is expressed in G0 cells. Northern blot 
analysis of total RNA from synchronized T98G cells revealed 
a transcript of the expected size and confi  rmed the results we 
obtained with RT-PCR (unpublished data).
To examine SCAPER protein levels, we produced and 
affi  nity purifi  ed a polyclonal antibody against an internal frag-
ment of SCAPER located close to the N terminus. SCAPER 
was the predominant polypeptide visualized by Western blot-
ting of crude cell lysates (Fig. 2, D and E), and it was expressed 
in every cell line we have tested, including immortal (T98G, 
U2OS, HeLa, 293T, Saos2) and normal diploid (IMR90, WI38) 
human cell lines, and mouse myoblast C2C12 cells (unpub-
lished data). We examined SCAPER protein levels as cells 
progress from G0 to S phase and in cells progressing from the 
G1/S transition. Consistent with our analysis of RNA, SCAPER 
is expressed at relatively constant levels throughout the cell 
cycle, including G0, although it was slightly elevated in early 
S phase (Fig. 2, D and E).
SCAPER speciﬁ  cally interacts with 
cyclin A/Cdk2 in vivo
Our initial identifi  cation of SCAPER was based on the observa-
tion that it stably interacts with cyclin A/Cdk2. Given that Cdk 
substrates are generally capable of associating with multiple 
cyclin/Cdk complexes, we asked whether SCAPER also interacts 
with other cyclins or Cdks in vivo. Endogenous SCAPER could 
be immunoprecipitated from cell extracts with anti-cyclin A 
or anti-Cdk2 antibody, but not with anti-cyclin E or anti-Cdk1 
antibody (Fig. 3 A). This suggests that SCAPER specifi  cally inter-
acts with cyclin A/Cdk2, but not with cyclin A/Cdk1, cyclin B/
Cdk1, or cyclin E/Cdk2, in vivo, within the detection limits of our 
Western blot analysis. This in vivo interaction was also detected 
using normal human diploid fi  broblasts (IMR90) and mouse 
myoblasts (unpublished data). Similar results were obtained 
when we transiently transfected 293 cells with a Flag-SCAPER 
expression vector, immunoprecipitated the protein with anti-
Flag antibodies, and performed Western blotting with antibodies 
against different cyclins and Cdks. We observed coimmuno-
precipitation of Flag-SCAPER with cyclin A and Cdk2, but not 
with cyclin E or Cdk1 (Fig. 4 B, lane 9). Next, we investigated 
the interaction between SCAPER and cyclin A at different cell 
cycle stages in T98G cells rendered quiescent and restimulated 
to enter the cell cycle. Like SCAPER, Cdk2 levels were rela-
tively constant throughout the cell cycle (Fig. 3 B). In contrast, 
cyclin A expression peaks in S/G2 phase, after which it decreases 
(Fig. 3 B), as expected. Interestingly, cyclin A associates with 
SCAPER whenever it is expressed (Fig. 3 B). Collectively, our 
results demonstrate that SCAPER specifi  cally interacts with 
cyclin A/Cdk2 at multiple phases of the cell cycle, including 
S and G2/M.
We investigated whether SCAPER/cyclin A/Cdk2 com-
plexes also contained members of the Kip/Cip family of Cdk 
inhibitory proteins and/or F-box family proteins. Strikingly, we 
Figure 2.  mRNA and protein expression of SCAPER. (A) Full-length SCAPER (lane 2) was cloned as a Flag-tagged fusion protein, expressed in 293 cells, 
immunoprecipitated with anti-Flag beads, and phosphorylated with recombinant GST-cyclin A/Cdk2 in vitro. Endogenous cyclin A/Cdk2/SCAPER com-
plex isolated by immunopuriﬁ  cation with cyclin A antibody was used as a control (lane 1). (B) Expression of SCAPER in human tissues. mRNA from different 
human tissues was probed with a SCAPER cDNA, and β-actin was used as a control. PBL: peripheral blood lymphocytes. (C) SCAPER mRNA expression 
across the cell cycle. T98G cells were synchronized by serum deprivation and restimulation with FBS. Semi-quantitative RT-PCR was used to measure 
SCAPER mRNA levels, and β-actin was used as a loading and normalization control. (D and E) Western blotting of endogenous SCAPER. (D) T98G cells 
were synchronized by serum deprivation and restimulation. β-Tubulin was used as a loading control. (E) U2OS cells were synchronized to G1, G1/S, S, 
and G2/M with drugs.SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 625
found that immunoprecipitates of p21 and p27 contained cyclin A 
and Cdk2, as expected, but not SCAPER (Fig. 3 C). Thus, the 
SCAPER/cyclin A/Cdk2 complex is separable from the pools of 
cyclin A/Cdk2/p21 and cyclin A/Cdk2/p27, and this fi  nding is 
consistent with our immunodepletion experiments (unpublished 
data). Furthermore, we note that immunoprecipitates of another 
cyclin A–interacting protein, Skp2, do not contain SCAPER 
(unpublished data).
A single cyclin-binding motif at the 
N-terminal region of SCAPER is 
responsible for cyclin A/Cdk2 interaction
To identify the region in SCAPER that confers binding to cyclin 
A/Cdk2, N-terminal (residues 1–717; SCAPER-N) and C-
terminal (residues 717–1399; SCAPER-C) fragments of SCAPER 
were fused to a Flag tag and expressed in both bacteria and 
mammalian cells (Fig. 4 A). Subsequent immunoprecipitation 
of transfected human 293T cells revealed that cyclin A and 
Cdk2 strongly associated with Flag-SCAPER-N, but only weak 
interactions were evident with Flag-SCAPER-C (Fig. 4 B). 
Identical results were obtained when bacterially expressed Flag-
SCAPER-N and Flag-SCAPER-C were incubated with recom-
binant GST-cyclin A/Cdk2 (Fig. 4 C). Thus, the N-terminal region 
of SCAPER is responsible for cyclin A/Cdk2 binding, and the 
interaction between SCAPER and this kinase is direct. Further, 
kinase assays revealed that cyclin A/Cdk2 phosphorylates Flag-
SCAPER-N but not Flag-SCAPER-C (Fig. 4 D), suggesting that 
cyclin A/Cdk2 can both bind and phosphorylate the N-terminal 
half of SCAPER. We note that the addition of excessive amounts 
of exogenous SCAPER did not substantially inhibit cyclin A/
Cdk2 kinase activity, suggesting that this fragment of SCAPER 
is not a Cdk inhibitor (Fig. 4 D and unpublished data).
Previous work revealed that RXL motifs in Cdk-interacting 
proteins are responsible for stable interactions with cyclin/Cdks 
(Zhu et al., 1995; Adams et al., 1996; Chen et al., 1996), and 
we ex  amined the requirement for this motif in SCAPER. The 
N-terminal portion of SCAPER confers cyclin A/Cdk2 binding 
(Fig. 4, B and C), and given that there are three cyclin-binding 
motifs in SCAPER-N, we mutated each of them in the context 
of full-length SCAPER to generate mutants mA, mB, and mC 
(Fig. 4 A). Each mutant was expressed in 293T cells. Immuno-
precipitation and Western blotting clearly show that mutants mA 
and mC retain the ability to bind to cyclin A/Cdk2 to the same 
extent as wild-type SCAPER (Fig. 4 B). In contrast, mB is un-
able to associate with cyclin A/Cdk2 (Fig. 4 B), indicating that 
this region constitutes a bona fi  de cyclin-binding motif.
SCAPER is a perinuclear protein localized 
to the nucleus and primarily to the ER
To biochemically examine the subcellular localization of 
SCAPER, we fractionated cell extracts into nuclear, cytosolic, 
and membrane compartments and verifi  ed enrichment of each 
fraction using several well-established markers (Fig. 5 A). 
Cyclin A is found predominantly in the nucleus, whereas Cdk2 
is found in both the nucleus and the cytosol, in agreement with 
earlier reports (Pines and Hunter, 1991; Bresnahan et al., 1996; 
Jackman et al., 2002). Interestingly, SCAPER is most enriched 
in the membrane fraction, similar to an ER membrane protein 
Figure 3. SCAPER  speciﬁ  cally interacts with cyclin A/Cdk2 and does not interact with p21 or p27 in vivo. (A) Western blotting of endogenous SCAPER, 
cyclin A, cyclin E, Cdk1, and Cdk2 after immunoprecipitation with the various antibodies indicated or control (anti-calnexin) antibody from 293T cell extracts. 
IN represents input. The size of cyclin E in the input lane appears to be slightly larger than the one detected in the IP lanes. This phenomenon occurred spo-
radically and is likely ascribed to ﬂ  uctuations in electrophoresis and/or transfer conditions. (B) SCAPER interaction with cyclin A across the cell cycle. T98G 
cells were synchronized by serum starvation and restimulated. (Top) Western blotting of endogenous SCAPER, cyclin A, and Cdk2. Actin was used as a load-
ing control. (Bottom) Western blotting of endogenous SCAPER and Cdk2 after immunoprecipitation with an anti-cyclin A antibody. (C) Western blotting 
of endogenous SCAPER, cyclin A, Cdk2, p21, or p27 after immunoprecipitation with control (anti-calnexin), p21, or p27 antibody from U2OS cell extracts. 
IN represents input.JCB • VOLUME 178 • NUMBER 4 • 2007  626
calnexin, although a portion was also detectable in the nuclear 
fraction (Fig. 5 A). This is in contrast to a Golgi resident protein 
giantin, which is located exclusively in the membrane fraction. 
Further, cyclin A resident in these membrane fractions was asso-
ciated with SCAPER (Fig. 5 B). We estimate, based on our sub-
cellular fractionation and RNAi experiments (see Fig. 8 B), that 
 10–20% of the total cellular cyclin A is bound to SCAPER. 
Given that the ER is contiguous with the nuclear envelope and that 
most rough ER membrane proteins are present in both the rough 
ER and the nuclear envelope (Klopfenstein et al., 2001), these 
data could suggest that SCAPER is a component of the ER.
Next, we used indirect immunofl  uorescence to further in-
vestigate the subcellular localization of SCAPER. Endogenous 
SCAPER was associated mostly with perinuclear and reticular 
structures (Fig. 5 C), with a small but detectable portion localized 
to the nucleus. Use of a second affi  nity-purifi  ed anti-SCAPER 
antibody directed against a different epitope gave similar results 
(unpublished data). We examined the localization of recombinant 
SCAPER by transfecting Flag-tagged SCAPER into U2OS cells, 
and indistinguishable results were obtained (Fig. 5 C). Compara-
ble fi  ndings were obtained using multiple human cell lines. To 
more precisely localize SCAPER within the perinuclear region, 
we performed colocalization experiments with GFP-tagged 
mannosidase II and GFP-tagged sec61β in the absence or presence 
of nocodazole. Mannosidase II is a luminal protein found in the 
medial compartment of the Golgi. Its staining did not substan-
tially overlap with that of SCAPER (Fig. 5 D). On the other hand, 
sec61β, a subunit of the heteromeric sec61 translocation com-
plex found in the membrane of the ER, exhibited substantial 
overlap with SCAPER (Fig. 5 D), indicating that SCAPER may 
localize to the ER. To test this idea further, we treated cells with 
a low dose of nocodazole, which depolymerizes microtubules 
and causes the Golgi to break down into small fragments contain-
ing mannosidase II that are dispersed throughout the cytoplasm 
(Fig. 5 D). In contrast, ER proteins such as sec61β are not af-
fected by nocodazole, and likewise, the distribution of SCAPER 
was not substantially altered by such treatment (Fig. 5 D). Use 
of a different drug, brefeldin A, which induces relocalization of 
Golgi proteins to the ER, has no effect on SCAPER localization 
(unpublished data). Collectively, subcellular fractionation and 
the immunofl  uorescence experiments confi  rm that SCAPER is 
an integral component of the ER.
Ectopic expression of SCAPER alters 
cyclin A localization and affects 
M phase progression
To study the effect of SCAPER expression on endogenous 
cyclin A, we ectopically expressed Flag-SCAPER in human cells. 
Figure 4.  A single RXL motif near the N-terminal of SCAPER binds speciﬁ  cally to cyclin A/Cdk2. (A) Schematic illustration of SCAPER and mutants. All con-
structs were fused to an N-terminal Flag tag. Amino acid residue numbers are stated. (B) Flag-tagged SCAPER mutants were expressed in 293 cells, immuno-
precipitated with anti-Flag antibodies, and immunoblotted with antibodies against cyclin A, cyclin E, Cdk2, and Cdk1. (C) Flag-tagged SCAPER-N, but not 
SCAPER-C, forms a complex with cyclin A/Cdk2 in vitro. Recombinant SCAPER deletion mutants were mixed with this kinase and puriﬁ  ed via the epitope 
tag on SCAPER. Antibodies used for immunoprecipitation and immunoblotting are indicated. (D) Flag-SCAPER-N but not Flag-SCAPER-C is efﬁ  ciently 
phosphorylated by cyclin A/Cdk2.SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 627
Immunofl  uorescence studies indicated that cyclin A localizes 
primarily to the nucleus, as expected (Fig. 6 A). However, when 
Flag-SCAPER was ectopically expressed, endogenous cyclin A 
was diffusely distributed throughout the cell. A substantial frac-
tion of cyclin A was sequestered outside of the nucleus in at 
least 70% of Flag-SCAPER–expressing cells (Fig. 6 A). During 
mitosis, the pattern of cyclin A in Flag-SCAPER–expressing 
cells looked indistinguishable from control cells (unpublished 
data). Interestingly, the Flag-SCAPER-N, mA, and mC SCAPER 
mutants, each of which retains an intact RXL motif (site B), 
potently sequestered cyclin A in the cytoplasm (Fig. 6 A and 
unpublished data). In sharp contrast, Flag-SCAPER-C and 
  mutant mB, which lacks this site, were unable to cause cyclin A 
relocation (Fig. 6 A and unpublished data). Similar results 
were obtained with other human cell lines. These data strongly 
suggest that the change in cyclin A localization was medi-
ated by SCAPER binding to cyclin A in the cytoplasm. Thus, 
the expression of SCAPER can dominantly interfere with 
cyclin A localization.
If SCAPER specifi  cally associates with cyclin A/Cdk2, 
and cyclin A/Cdk2 is required at distinct stages of the cell cycle, 
ectopic expression of SCAPER might be expected to affect cell 
cycle distribution. We transiently expressed Flag-tagged SCAPER 
and several mutants in human cells and examined their cell 
cycle distribution at different intervals after transfection using 
fl  ow cytometry. SCAPER expression initially caused a modest 
increase in the S phase population that eventually led to a prom-
inent G2/M accumulation 72 h after transfection (Fig. 6, B and C). 
To pinpoint the stage at which the arrest occurred, we compared 
the mitotic index of transfected versus untransfected cells by 
visualizing cells that exhibit phosphorylation of serine 10 of 
histone H3, a well-established marker of mitosis (Hendzel et al., 
1997). Microscopic examination revealed a fourfold enrichment 
of mitotic cells expressing Flag-SCAPER (13.3 ± 3.6%) as 
compared with control mitotic cells (2.8 ± 0.7%) (Fig. 6 D). 
DAPI staining revealed that these cells had condensed chromo-
somes. To more precisely determine whether this enrichment 
in mitotic cells stemmed from a cell cycle block or a delay, 
we blocked transfected cells at the G1/S phase border with 
  hydroxyurea (HU). After treatment with HU, the mitotic index 
of control (0.5 ± 0.1%) and SCAPER-expressing cells (0.7 ± 
0.1%) did not differ substantially (Fig. 6 D), suggesting that 
SCAPER overexpression results in an M phase delay rather 
than an arrest. Furthermore, the proportion of prophase cells in 
SCAPER-expressing mitotic cells was slightly elevated com-
pared with that in control mitotic cells, suggesting the delay 
Figure 5.  Subcellular localization of SCAPER. (A) Subcellular fractionation in U2OS cells. 50 μg of proteins from nuclear, cytosolic, and membrane compo-
nents were resolved by SDS-PAGE and blotted with the antibodies indicated. IN represents whole cell extract. (B) Western blotting of endogenous SCAPER, 
cyclin A, and Cdk2 after immunoprecipitation with control (anti-Flag) or anti-cyclin A antibody using the membrane fraction from subcellular fractionation. IN 
represents input. (C) U2OS cells (top row) or U2OS cells expressing Flag-SCAPER (bottom row) were ﬁ  xed and incubated with afﬁ  nity-puriﬁ  ed anti-SCAPER anti-
body (red, top row) or anti-Flag antibody (green, bottom row), and DAPI. Bar, 10 μm. (D) U2OS cells transfected with either GFP-mannosidase II or GFP-sec61β 
were treated with or without 10 μM nocodazole for 3 h, ﬁ  xed, and incubated with afﬁ  nity-puriﬁ  ed anti-SCAPER antibody (red) and DAPI. Bar, 10 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  628
may occur at this stage in mitosis (unpublished data). Studies 
using deletion mutants showed that Flag-SCAPER-N, but not Flag-
SCAPER-C, produced a similar cell cycle phenotype (Fig. 6 C), 
and a striking accumulation was also evident when cells were 
transfected with mutants mA and mC (Fig. 6 C). In contrast, ex-
pression of mutant mB, which lacks the ability to bind cyclin A/
Cdk2, had only a modest effect on cell cycle progression (Fig. 6 C). 
Collectively, our data suggest that expression of SCAPER can 
affect cell cycle progression specifi  cally in M phase by bind-
ing and sequestering cyclin A/Cdk2.
Depletion of SCAPER results in a delayed 
S phase reentry from quiescence
We investigated the effects of suppressing SCAPER production 
by RNAi-mediated down-regulation of endogenous SCAPER. 
siRNAs corresponding to four distinct SCAPER coding sequences 
were chosen to target SCAPER in human cells. Western blot anal-
ysis showed that treatment of cells with SCAPER siRNA resulted 
in a substantial reduction ( 75%) in SCAPER expression (Fig. 
7 C). Fluorescence-activated cell sorting (FACS) analysis of trans-
fected cells indicated that cell cycle progression was not affected 
in cycling cells, and SCAPER siRNA-treated cells released from 
an HU block progressed through S phase and G2/M phase with 
kinetics similar to control cells (unpublished data). Microscopic 
inspection of transfected cells also did not reveal obvious abnor-
malities. In particular, immunofl  uorescence studies failed to de-
tect any changes in the levels or in the subcellular localization 
of cyclin A, Cdk2, γ-tubulin, or calnexin. DNA staining also ap-
peared similar in control and knock-down samples.
SCAPER expression is not cell cycle dependent (Fig. 2, 
D and E), and depletion of SCAPER had no obvious impact on 
cycling cells. However, the presence of abundant SCAPER in 
G0 cells (Fig. 2 D) prompted us to investigate the effect of 
SCAPER depletion on the ability of cells to exit the cell cycle or 
to reenter the cell cycle from quiescence (Fig. 7 A). First, there 
was no apparent impact of SCAPER depletion on entry into 
Figure 6.  Expression of SCAPER sequesters cyclin A in the cytoplasm and causes accumulation of cells in M phase. (A) Saos2 cells were transiently trans-
fected with Flag, Flag-SCAPER, Flag-mA, Flag-mB, or Flag-mC. Cells were ﬁ  xed and stained with anti-Flag, anti-cyclin A antibodies, and DAPI. Bar, 10 μm. 
(B) The effect of SCAPER on Saos2 cell cycle distribution. Saos2 cells were transiently transfected with pCMV-CD20 and either Flag or Flag-SCAPER. Cells 
were harvested and analyzed by ﬂ  ow cytometry. FACS proﬁ  les were gated for CD20 ﬂ  uorescence. (C) The effect of SCAPER deletion (SCAPER-N and 
SCAPER-C) and RXL (mA, mB, and mC) mutants on cell cycle distribution. Saos2 cells were transiently transfected with pCMV-CD20 and either Flag, Flag-
SCAPER, Flag-SCAPER-N, Flag-SCAPER-C, Flag-mA, Flag-mB, or Flag-mC. Cells were harvested and analyzed by ﬂ  ow cytometry. The full-length and mutant 
proteins were detected by Western blotting and were expressed to a similar extent after transfection. For each construct, the experiments were repeated 
at least twice. (D) U2OS cells were transiently transfected with Flag or Flag-SCAPER. They were either left untreated or treated with HU to enrich for G1/S 
cells. The percentage of mitotic cells in each population was determined by examining cells exhibiting condensed chromosomes marked with p-Ser10-H3. 
At least 100 cells were scored for each condition, and the experiments were repeated twice.SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 629
quiescence (Fig. 7 B; row 1, columns 1 and 2), suggesting that 
ablation of SCAPER does not affect cell cycle exit in response 
to mitogen deprivation. Next, SCAPER-depleted cells brought 
to quiescence through serum deprivation were restimulated. As 
expected, a substantial number of cells transfected with control 
siRNA entered S phase  18 h after serum stimulation (40%, 
Fig. 7 B; row 4, column 1), and by 21 h, 99% of cells were in 
S phase (Fig. 7 B; row 5, column 1). 60% of cells progressed into 
G2/M phase 3 h later (Fig. 7 B; row 6, column 1). In striking 
contrast, the majority of SCAPER siRNA-treated cells were still 
in G1 18 h after stimulation (81%, Fig. 7 B; row 4, column 2). By 
21 h after stimulation, a substantial proportion of these cells be-
gan to enter the S phase (57%) (Fig. 7 B; row 5, column 2). Only 
2% of cells had progressed into G2/M phase after 24 h (Fig. 7 B; 
row 6, column 2). Thus, there appears to be a considerable delay 
( 3 h in duration) in S phase entry associated with SCAPER 
depletion. Consistent with our FACS analysis, we observed 
a comparable delay in BrdU incorporation associated with 
SCAPER depletion in siRNA-treated cells (Fig. 7 D). Importantly, 
this cell cycle delay phenotype was also observed with three ad-
ditional, distinct siRNAs targeting SCAPER (Fig. S1 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200701166/DC1). 
Furthermore, similar fi  ndings were observed in normal human 
cell lines such as IMR90 and WI38 (unpublished data), and 
in mouse 3T3 cells using a mouse-specifi  c SCAPER siRNA 
(Fig. S1 B). Collectively, we conclude that SCAPER plays a 
critical role in promoting progression from G1 to S phase after 
cell cycle reentry from a quiescent state.
We attempted to pinpoint more precisely when the cell 
cycle delay takes place. We determined whether escape from 
the quiescence state was impaired in cells depleted of SCAPER 
by counting cells that expressed the Ki67 proliferation marker, 
apparent only in nonquiescent cells. Interestingly, both control 
and SCAPER siRNA-transfected cells were able to exit G0 with 
Figure 7.  Ablation of SCAPER with siRNA results in a delayed G1/S transition upon cell cycle reentry from G0. (A) An illustration of the experimental pro-
tocol for studying the effects of SCAPER depletion. T98G cells were transfected with either control or SCAPER siRNAs and were synchronized by serum 
dep  rivation. Cells were harvested at various time points upon restimulation. (B) FACS analysis. (C) Western blotting of endogenous SCAPER. β-Tubulin 
was used as a loading control. (D) Control or SCAPER-siRNA treated quiescent T98G cells were restimulated, and BrdU was added to the media 1 h before 
ﬁ  xation. Cells were then stained with anti-BrdU antibody and DAPI. The percentage of BrdU-positive cells is presented. (E) Control or SCAPER-siRNA treated 
quiescent T98G cells were restimulated, ﬁ  xed, and stained with anti-Ki67 antibody and DAPI. The percentage of Ki67-positive cells is presented. At least 
100 cells were scored for each time point, and the experiments were performed twice. (F) Control or SCAPER-siRNA treated quiescent T98G cells were 
restimulated and blocked in G1/S with HU. They were subsequently released to allow entry into S phase.JCB • VOLUME 178 • NUMBER 4 • 2007  630
similar kinetics (Fig. 7 E). Furthermore, when G0 cells were 
released and synchronized at the G1/S boundary with HU, 
SCAPER depleted cells progressed into the S phase more slowly 
than control cells after release from the HU block (Fig. 7 F). 
Collectively, we believe that the S phase delay occurs in late 
G1/S and not earlier in the cell cycle (G0 or early G1 phase).
Ablation of SCAPER with siRNA alters 
cyclin A localization
We reported that overexpression of SCAPER results in the re-
localization of cyclin A from the nucleus to the cytoplasm (Fig. 
6 A). We sought to determine whether the converse is true, namely, 
whether cyclin A would relocalize from the cytoplasm when 
SCAPER function is suppressed. We and others have detected a 
portion of cyclin A residing within the cytoplasm and the micro-
somes (Girard et al., 1991; Carbonaro-Hall et al., 1993; Castro 
et al., 1994). This cyclin A partitioning is diffi  cult to detect by 
immunofl  uorescence or live-cell imaging. Not surprisingly, when 
U2OS cells were transfected with either control or SCAPER 
siRNA, no difference in cyclin A staining in the cytoplasm was 
observed (Fig. 8 A, columns 1 and 2). To overcome this limita-
tion, cells were fi  rst transfected with Flag-SCAPER to seques-
ter cyclin A in the cytoplasm. They were subsequently treated 
with either control (Fig. 8 A, column 3) or SCAPER siRNA 
(Fig. 8 A, column 4) to gauge the effects of knock-down. Upon 
silencing SCAPER, we observed recycling of cyclin A from the 
cytoplasm back to the nucleus (Fig. 8 A, column 4). Thus, 
SCAPER can infl  uence the balance between cytoplasmic and 
nuclear pools of cyclin A, and it may represent a novel cyclin A/
CDK2 regulatory protein that transiently maintains this kinase 
outside of the nucleus.
As a further confi  rmation that RNAi-mediated depletion 
of SCAPER alters cyclin A localization, we performed a series 
of subcellular fractionation experiments to examine the dynamic 
equilibrium of cyclin A in distinct cellular compartments, at a 
time when the cell cycle delay phenotype was fi  rst evident at 
late G1/S (15 and 18 h after serum stimulation as in Fig. 7 B, 
rows 3 and 4). For control siRNA-treated cells, we found that 
17 and 26% of total cellular cyclin A was associated with the 
membrane compartment 15 and 18 h after stimulation, respec-
tively (Fig. 8 B). Remarkably, the membrane-bound cytoplasmic 
pool of cyclin A was dramatically reduced when SCAPER 
was depleted. Thus, after SCAPER suppression, we observed 
only 2% of total cellular cyclin A associated with the mem-
brane fraction 15 h after stimulation, and at 18 h after release, 
the percentage of cyclin A residing in the membrane increased 
to only 12% (Fig. 8 B). Consistent with decreased cyclin A re-
tention at membranes, we observed a comparable reduction in 
Figure 8.  Ablation of SCAPER with siRNA releases cyclin A from the cytoplasm. (A) U2OS cells were transfected with either Flag or Flag-SCAPER. 1 d later, 
they were transfected with either control or SCAPER siRNA. 1 d after siRNA transfection, cells were blocked with and released from HU, and processed for 
immunoﬂ  uorescence studies with anti-Flag, anti-cyclin A antibodies, and DAPI. Bar, 10 μm. (B) T98G cells were transfected with either control or SCAPER 
siRNA and were synchronized in G0. Upon restimulation, cells were harvested and were subsequently subjected to subcellular fractionation. 50 μg of protein 
from nuclear, cytosolic, or membrane fraction were resolved by SDS-PAGE and blotted with the antibodies indicated. The percentage of cyclin A or Cdk2 in 
each fraction (expressed as a percentage of the total cellular cyclin A or Cdk2) is stated above each blot. (C) A model implicating SCAPER in the regulation 
of cyclin A/Cdk2 activity. SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 631
membrane-associated Cdk2 in SCAPER-depleted cells at 15 
and 18 h after stimulation (Fig. 8 B). As a further test of the 
notion that partitioning of cyclin A within the cytoplasm by 
SCAPER occurred at a critical time in late G1/S phase when 
cyclin A levels were limiting, we compared the proportions of 
cyclin A in different compartments at a time when SCAPER is 
not thought to play a role, namely, after S phase entry (24 h, 
Fig. 8 B), and we did not observe any substantial difference be-
tween the two populations. In addition, consistent with cyclin A 
partitioning in SCAPER-depleted cells, no apparent difference 
in Cdk2 localization was observed in cells that had entered S 
phase (24 h, Fig. 8 B). In conclusion, our studies strongly sup-
port the notion that ablation of SCAPER decreases the pool of 
cyclin A in the cytoplasm and results in a delayed S phase re-
entry from quiescence. We have therefore for the fi  rst time 
unraveled the physiological signifi  cance of SCAPER and its 
role in maintaining cyclin A homeostasis in the cytoplasm.
Discussion
One enduring, fundamental issue in the fi  eld of cell cycle con-
trol pertains to our incomplete knowledge of Cdk substrates 
(Sanchez and Dynlacht, 2005). We isolated and purifi  ed a novel 
protein, SCAPER, which specifi  cally interacts with cyclin A/
Cdk2 both in vitro and in vivo. SCAPER is expressed in quies-
cent cells and its levels remain relatively unchanged throughout 
the cell cycle, suggesting that it may have a housekeeping function. 
It localizes primarily to the ER and interacts with cyclin A at 
multiple phases of the cell cycle. Progression through two key 
cell cycle transitions, G1/S and M phase, is differentially 
affected by SCAPER. Ablation of SCAPER by RNAi leads to 
delay of cell cycle reentry into S phase, but overexpression pro-
vokes cell cycle delay in M phase. These data lead us to propose 
an intriguing hypothesis: cytoplasmic cyclin A may be a limit-
ing factor for the G1/S transition upon cell cycle reentry from 
quiescence; that is, cyclin A could be tethered to the ER, retain-
ing it in the cytoplasm, where it may be required to phosphory-
late a key substrate before S phase reentry. On the other hand, 
nuclear cyclin A may play a more prominent role in progression 
through the G2/M phase transition.
The presence of cyclin A/Cdk2 complexes in the cyto-
plasm is in accordance with the notion that cyclin A/Cdk2 phos-
phorylates substrates in that compartment as well as the nucleus. 
A requirement for cytoplasmic pools of cyclin A/Cdk2 is sub-
stantiated by recent studies implicating this kinase in mamma-
lian centrosome duplication (Meraldi et al., 1999) and by other 
experiments that have identifi  ed Cdk2 targets associated with 
this organelle (Okuda et al., 2000; Fisk and Winey, 2001; Chen 
et al., 2002). Recent studies have shown that the nuclear import 
of cyclin A is much more rapid than its export (Jackman et al., 
2002). In light of these observations, we believe that our identi-
fi  cation of SCAPER has several important implications for the 
partitioning and regulation of cyclin A/Cdk2 activity and its 
targets (Fig. 8 C). First, because nuclear import of cyclin A/Cdk2 
is kinetically favored over its export, it may be necessary to se-
quester the small quantities of this kinase that enter the cyto-
plasm at any given time. SCAPER, or an analogous cyclin A/Cdk2 
binding protein, may perform such a function by partitioning 
cyclin A in the cytoplasm. In this regard, SCAPER may play a 
more prominent role during the G1/S transition in cells reenter-
ing the cell cycle from quiescence, whereas an analogous cyclin A/
Cdk2 binding protein could substitute for SCAPER function 
at other stages of the cell cycle. Furthermore, we note that 
SCAPER is present in quiescent and early G1 phase cells. It 
could therefore play a second, “buffering” role, to scavenge small 
quantities of cyclin A present in early G1 cells that could trigger 
premature initiation of DNA replication. In contrast, cyclin A 
levels rise dramatically during S phase and could thereby exceed 
the amount of SCAPER, allowing nuclear localization of cyclin A/
Cdk2. SCAPER could thus provide a threshold function, deli-
cately balancing the amount of cyclin A/Cdk2 partitioned between 
the two cellular compartments (Fig. 8 C).
Although we do not yet know the precise mechanism by 
which SCAPER overexpression affects M phase, it does not ap-
pear to result from the direct attenuation of cyclin A/Cdk2 activity 
because excessive amounts of recombinant SCAPER do not sub-
stantially inhibit Cdk2 activity (Fig. 4 D and unpublished data). 
It is more likely that ectopic expression of SCAPER induces 
a cell cycle delay by sequestering the bulk of cyclin A/Cdk2 away 
from the pool of cyclin A complexes that normally interact with 
the Kip/Cip family of inhibitors (p21, p27) and the pRB family 
(p107 and p130) in the nucleus, thereby preventing the phosphoryla-
tion of critical substrates necessary for progression through M 
phase. Indeed, SCAPER represents a unique tool for dissecting 
the function of cyclin/Cdk complexes. It appears to be the fi  rst 
protein shown to preferentially interact with cyclin A/Cdk2 to 
the apparent exclusion of all other cyclin/Cdk complexes.
Recent evidence has implicated a role for cytoplasmic 
cyclin A in oncogenesis. Cytoplasmic accumulation of cyclin A 
has been reported in tumor cells (Aaltomaa et al., 1999a,b). In 
addition, targeting of cyclin A to the ER in normal rat fi  broblasts 
leads to oncogenic activation and results in polyploidy, abnormal 
centrosome duplication, and genomic instability (Berasain et al., 
1998; Faivre et al., 2002). These studies raise the intriguing 
possibility that an increase in cytoplasmic cyclin A levels is the 
direct cause of cellular transformation. As SCAPER possesses 
the ability to bind cyclin A in the cytoplasm, experiments are 
currently underway to determine precisely whether SCAPER 
up-regulation, which could lead to an increase of cytoplasmic 
cyclin A, is a common hallmark in cancer cells. If so, suppres-
sion of SCAPER function in tumor cells could be a major poten-
tial therapeutic application for SCAPER.
Materials and methods
Cell culture
HeLa, 293T, T98G, U2OS, IMR90, WI38, Saos2, and mouse C2C12 and 
3T3 cells were grown in DME supplemented with 10% FBS at 37°C in a 
humidiﬁ  ed 5% CO2 atmosphere.
Production of recombinant proteins
Recombinant GST protein was expressed in bacteria transformed with 
pGEX2TK. GST-cyclin A/Cdk2 and GST-cyclin E/Cdk2 were produced in 
Hi5 insect cells by co-infection with viruses carrying GST-cyclin A and 
Cdk2 or GST-cyclin E and Cdk2. Fusion proteins were puriﬁ  ed by afﬁ  nity 
chromatography with glutathione agarose (Sigma-Aldrich) as described 
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buffer (25 mM Hepes, pH 7.6, 100 mM KCl, 0.2 mM EDTA, pH 8.0, 12.5 
mM MgCl2, 0.1% NP-40, and 1 mM DTT with a cocktail of protease and 
phosphatase inhibitors). Cell extracts were incubated with glutathione aga-
rose for 1 h at 4°C. The beads were collected by centrifugation, washed 
4 times with 0.1 HEMGN buffer, and eluted with 20 mM glutathione in buffer 
containing 100 mM Tris (pH 7.9) and 120 mM NaCl. Flag-SCAPER-N and 
Flag-SCAPER-C were expressed in Escherichia coli strain BL21 transformed 
with RSET vectors containing Flag-SCAPER-N and Flag-SCAPER-C, and Flag-
SCAPER was expressed in human 293 cells transfected with CBF-SCAPER, 
and puriﬁ  ed with anti-Flag agarose (M2, Sigma-Aldrich). The relative pro-
tein concentrations were estimated by silver or Coomassie staining.
SCAPER puriﬁ  cation and sequencing
Human 293 cells were lysed in ELB buffer (50 mM Hepes, pH 7.0, 250 mM 
NaCl, 0.5 mM EDTA, pH 8.0, 0.1% NP-40, and 1 mM DTT with a cocktail 
of protease and phosphatase inhibitors) for 30 min on ice and then centri-
fuged at 20,000 g for 30 min. The supernatant (1 g of total protein) was 
precleared three times by incubation with glutathione agarose loaded with 
 50 μg of GST for 2 h at 4°C. The precleared supernatant was incubated 
with glutathione agarose loaded with  40 μg GST-cyclin A/Cdk2 for 4 h 
at 4°C. The beads were collected by centrifugation and washed four times 
with ELB buffer. Finally, the beads were boiled in SDS sample loading buffer 
and analyzed by 10% SDS-PAGE. The gel was stained with silver. Immuno-
depletion and immunoprecipitation coupled to Western blotting with anti-
bodies against p21, p27, p107, and p130 (Santa Cruz Biotechnology, Inc.) 
were used to identify each of the proteins in the eluate. The 158/160-kD 
band was excised from the gel, subjected to tryptic digestion, and the re-
sulting peptides were separated by reverse-phase HPLC and analyzed with 
an LCQ quadrupole ion trap mass spectrometer (Finnigan) in the Harvard 
Microchemistry Facility.
SCAPER cloning and plasmid construction
SCAPER cDNA was generated using SuperScript II H
− Reverse Transcriptase 
(Life Technologies) according to the manufacturer’s protocol. The primers 
for the reverse transcription reactions were AAC AAG GGT ACT CAA ATA 
CAG and AGC TCT TTC CCG GGC TGC ATC. The entire coding region 
was ampliﬁ  ed by two PCR steps with PfuTurbo DNA polymerase (Strata-
gene) using the two fragments of the ﬁ  rst strand of SCAPER cDNA as 
templates. The product was sub-cloned into an expression vector (CBF; 
M. Cole, Princeton University, Princeton, NJ) in frame with the N-terminal 
Flag tag to produce CBF-SCAPER.
CBF-SCAPER was digested with XmaI to produce two fragments of 
2.2 kb and 6.7 kb, and the 2.2-kb fragment was sub-cloned into CBF XmaI 
site to generate CBF-SCAPER-N, which expresses amino acids 1–717 of 
SCAPER. The 6.7-kb fragment of DNA was treated with T4 polymerase to 
create blunt ends and re-ligated to generate CBF-SCAPER-C, which en-
codes amino acid residues 717–1399. The bacterial expression plasmids 
corresponding to SCAPER-N and SCAPER-C have an N-terminal Flag tag 
and were constructed by cloning each into the RSET vector (Invitrogen).
To identify potential cyclin binding motifs in SCAPER, the ﬁ  rst three 
potential RXL sequences were changed to AAA to produce mutants mA, mB, 
and mC. Primers used in PCR mutagenesis were: AGC TAT TGC AGC AGC 
TGC TGT ACG ACC CTC CTC TGC and ACA GCA GCT GCT GCA ATA 
GCT TGG AGT GTT CCA CTA for mA, AAA ATT TGC AGC AGC TCG 
AGC ATT TGA TGT TAC ATT and GCT CGA GCT GCT GCA AAT TTT GGA 
GGT TCA ACT GGC for mB, TGC CTC TGC AGC AGC CTT GCG TTC 
CTG CAC AGC TTC and CGC AAG GCT GCT GCA GAG GCA GAG 
CGG CAG GCC CGT for mC. All constructs were veriﬁ  ed by sequencing.
RNA interference
Synthetic siRNA oligonucleotides were obtained from Dharmacon. Transfec-
tion of siRNAs using Oligofectamine (Invitrogen) was performed according to 
the manufacturer’s instructions. The 21-nucleotide siRNA sequence for the non-
speciﬁ  c control was 5′-A  A  T  T  C  T  C  C  G  A  A  C  G  T  G  T  C  A  C  G  T  -3′. The 21-nucleotide 
siRNA sequence for SCAPER-1 was 5′-G  A  A  T  A  A  A  C  G  T  C  A  T  G  A  T  G  T  T  T  T  -3′.
RNA preparation and quantitative RT-PCR
Total RNA was prepared using Trizol Reagent (Life Technologies) according 
to the manufacturer’s protocol. Semi-quantitative RT-PCR was performed using 
RT-PCR Superscript One Step kit (Invitrogen) as described by the manufacturer. 
Linear ampliﬁ  cation was ensured in all cases. Primers for analysis of SCAPER 
expression were: CAG TGA TTT TTC TGC CAG CA and AGC TCT TTC CCG 
GGC TGC ATC; primers for analysis of β-actin levels were: ATC CTC ACC 
CTG AAG TAC CCC A and CTC GGC CGT GGT GGT GAA GCT GTA 
GCC GCG CT.
Cell cycle synchronization and FACS analysis
T98G cells were rendered quiescent by serum deprivation for 72 h and 
stimulated with 20% FBS to allow cell cycle reentry. Cell cycle synchroniza-
tion of T98G and U2OS cells was also performed by drug treatment. 
G1, G1/S, and G2/M cells were obtained by treating the cells for 24 h 
with 0.4 mM mimosine, 2 mM hydroxyurea, and 40 ng/ml nocodazole, 
respectively. S phase cells were obtained by releasing cells from hydroxy-
urea treatment into fresh medium for 4–6 h. Cell cycle distribution was 
monitored by propidium iodide staining and FACS analysis was performed 
as reported previously (Woo et al., 1997).
Transient transfection, cell cycle analysis, and colony growth assay
Transient transfections were performed using calcium phosphate (Chen 
and Okayama, 1987). For cell cycle analysis, the indicated plasmids 
(20 μg) were cotransfected with pCMV-CD20 (2 μg) into human cells and 
processed as described previously (Woo et al., 1997). Cells were harvested 
with phosphate-buffered saline (PBS) containing 0.1% EDTA and stained 
with anti-CD20-FITC (Sigma-Aldrich) before FACS analysis.
Antibodies
To generate anti-SCAPER antibodies, a GST fusion protein encoding resi-
dues 382–493 was produced in bacteria and used to immunize rabbits 
after coupling to keyhole limpet hemocyanin. Polyclonal antibodies against 
SCAPER were puriﬁ  ed using a GST-SCAPER fusion protein afﬁ  nity column 
after the serum was precleared with a GST protein afﬁ  nity column.
Immunoprecipitation, immunoblotting, and kinase assays
Cultured cells were washed once with PBS and lysed in ELB buffer. In a typi-
cal immunoprecipitation, whole-cell extract was incubated with antibodies 
for 2 h, and beads were washed four times with ELB buffer. Proteins bound 
to beads were eluted by boiling in sample buffer, separated by SDS-PAGE, 
transferred to a nitrocellulose membrane, and subjected to Western blot 
analysis. All kinase reactions were performed at 30°C in buffer containing 
25 mM Hepes, pH 7.6, 150 mM NaCl, 0.5 mM EDTA, pH 8.0, 10 mM 
MgCl2, 1 μM ATP, 1 mM DTT and 5 μCi 32γ-ATP (NEN Life Science Products). 
For immunoblotting, antibodies against cyclin A, cyclin B, cyclin E, Cdk2, 
Cdk1, Sp1 (each from Santa Cruz Biotechnology, Inc.), calnexin (BD 
Biosciences), giantin (Covance Research Products, Inc.), actin, β-tubulin, and 
Flag (each from Sigma-Aldrich) were used.
Immunoﬂ  uorescence
Indirect immunoﬂ  uorescence was performed as described previously (Chen 
et al., 2002). In brief, cells were grown on glass coverslips, ﬁ  xed with 4% 
paraformaldehyde and 0.1% glutaraldehyde in PBS for 10 min followed 
by incubation in −20°C methanol for 2–3 min. The cells were permeabil-
ized with 1% Triton X-100/PBS for 10 min. Slides were blocked with 3% 
BSA in 0.1% Triton X-100/PBS before incubation with primary antibodies. 
Antibodies against SCAPER, Flag, cyclin A, p-ser10-H3 (Upstate Bio-
technology), BrdU (Sigma-Aldrich), and Ki67 (Zymed Laboratories) were 
used. Secondary antibodies used were Cy3- or FITC-conjugated donkey 
anti–mouse or anti–rabbit IgG (Jackson ImmunoResearch Laboratories). 
Cells were then stained with DAPI and slides were mounted, observed, and 
photographed using a Nikon Eclipse E800 microscope (63× or 100×, 
NA 1.4) equipped with a Photometrics Coolsnap HQ CCD camera. Images 
were acquired with MetaMorph7 (Molecular Devices).
Subcellular fractionation
Cells were incubated in hypotonic lysis buffer (10 mM Tris, pH 8.0, 10 mM 
NaCl, 3 mM MgCl2, and 1 mM EGTA with a cocktail of protease and 
phosphatase inhibitors) for 10 min, followed by 20 strokes of a Dounce B 
homogenizer. The lysates were spun down for 5 min at 500 g, and the 
supernatant was designated the cytosolic fraction. The nuclear pellet was 
washed three times in wash buffer (hypotonic lysis buffer with 0.1% NP-40) 
and then treated with nuclear lysis buffer (20 mM Hepes, pH 8.0, 25% 
glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and 0.5 mM DTT 
with a cocktail of protease and phosphatase inhibitors) for 30 min. The 
sample was spun at 14,000 g for 30 min, and the supernatant designated 
the nuclear fraction. The cytosolic fraction was spun at 100,000 g for 2 h, 
and the pellet (which was designated as the membrane fraction) was re-
suspended in ELB buffer with 1% NP-40. To verify the integrity of each frac-
tion, Western blots were probed with nuclear (Sp1), cytosolic (β-tubulin), 
and membrane (calnexin and giantin) markers. For quantitation, 50 μg 
of protein from nuclear, cytosolic, or membrane fraction were resolved 
by SDS-PAGE and blotted with the antibodies indicated. The ﬁ  lms were 
scanned with an Epson Perfection 4990 scanner and band intensities were SCAPER REGULATES CYCLIN A/CDK2 • TSANG ET AL. 633
quantitated and analyzed using Bio-Rad Quantity One 1-D analysis software. 
The entire analysis was done within the linear range of detection.
Online supplemental material
Fig. S1 shows ablation of SCAPER with siRNA results in a delayed G1/S 
transition upon cell cycle reentry from G0. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200701166/DC1.
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